Cerebrospinal fluid profile of amyloid β42 (Aβ42), hTau and ubiquitin in North Indian Alzheimer's disease patients

[1]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  Guojun Bu,et al.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy , 2009, Nature Reviews Neuroscience.

[3]  H. Soininen,et al.  Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. , 2009, Archives of neurology.

[4]  Pradeep,et al.  Lower levels of cerebrospinal fluid amyloid ß (Aß) in non-demented Indian controls , 2006, Neuroscience Letters.

[5]  Antonio Federico,et al.  Cerebrospinal fluid tau, Aß, and phosphorylated tau protein for the diagnosis of Alzheimer's disease , 2006, Journal of cellular physiology.

[6]  Gina N. LaRossa,et al.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.

[7]  M. Yoshita,et al.  Decreased β-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration , 2005, Journal of the Neurological Sciences.

[8]  A. Verghese,et al.  Prevalence of dementia in an urban population in Kerala, India , 2005, British Journal of Psychiatry.

[9]  Holly Soares,et al.  Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele , 2004, Biological Psychiatry.

[10]  Juan Manuel Maler,et al.  Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau , 2004, Neurobiology of Aging.

[11]  Charles DeCarli,et al.  Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? , 2003, Archives of neurology.

[12]  K. Blennow,et al.  CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study , 2003, Neurology.

[13]  S. Sachdeva,et al.  Prevalence of Dementia in an Urban Indian Population , 2001, International Psychogeriatrics.

[14]  G. Cole,et al.  The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.

[15]  S. DeKosky,et al.  Incidence of Alzheimer’s disease in a rural community in India , 2001, Neurology.

[16]  K. Blennow,et al.  Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. , 2001, Archives of neurology.

[17]  Hilkka Soininen,et al.  Relationship between apoE genotype and CSF β-amyloid (1–42) and tau in patients with probable and definite Alzheimer’s disease , 2000, Neurobiology of Aging.

[18]  S. DeKosky,et al.  Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. , 2000, Archives of neurology.

[19]  H. Vanderstichele,et al.  Cerebrospinal beta-amyloid (1–42) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline , 2000, Neuroscience Letters.

[20]  K. Blennow,et al.  Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment , 1999, Neuroscience Letters.

[21]  P. Deyn,et al.  Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF , 1999, Neurology.

[22]  B Engvall,et al.  Cerebrospinal fluid Aβ42 is increased early in sporadic Alzheimer's disease and declines with disease progression , 1999, Annals of neurology.

[23]  K. Davis,et al.  CSF beta-amyloid, cognition, and APOE genotype in Alzheimer’s disease , 1999, Neurology.

[24]  S. Hirai,et al.  Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan , 1998 .

[25]  S. Hirai,et al.  Combination assay of CSF Tau, Aβ1-40 and Aβ1-42(43) as a biochemical marker of Alzheimer's disease , 1998, Journal of the Neurological Sciences.

[26]  L. Schad,et al.  Cerebral changes and cerebrospinal fluid β-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging , 1997, Molecular Psychiatry.

[27]  S. Hirai,et al.  Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease , 1997, Journal of the Neurological Sciences.

[28]  R. Motter,et al.  Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease , 1997 .

[29]  Hans Förstl,et al.  Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay* , 1996, The Journal of Biological Chemistry.

[30]  A. Kurz,et al.  Cerebrospinal protein tau is elevated in early Alzheimer's disease , 1996, Neuroscience Letters.

[31]  R. Wolfert,et al.  Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease , 1995 .

[32]  T. Kudo,et al.  Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels , 1994, Brain Research.

[33]  K. Blennow,et al.  Ubiquitin in Cerebrospinal Fluid in Alzheimer's Disease and Vascular Dementia , 1994, International Psychogeriatrics.

[34]  P. Lansbury,et al.  The C‐Terminus of the β Protein is Critical in Amyloidogenesis a , 1993 .

[35]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[36]  I. Grundke‐Iqbal,et al.  Brain ubiquitin is markedly elevated in Alzheimer disease , 1991, Brain Research.

[37]  D. Ecker,et al.  A human ubiquitin carboxyl extension protein functions in yeast. , 1990, The Journal of biological chemistry.

[38]  D. Dickson,et al.  Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[39]  R. Mayer,et al.  Ubiquitin-protein conjugates accumulate in the lysosomal system of fibroblasts treated with cysteine proteinase inhibitors. , 1989, The Biochemical journal.

[40]  V. Chau,et al.  Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Y. Ihara,et al.  Ubiquitin is a component of paired helical filaments in Alzheimer's disease. , 1987, Science.

[42]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[43]  B. Raboy,et al.  Effect of heat shock on protein degradation in mammalian cells: involvement of the ubiquitin system. , 1987, The EMBO journal.

[44]  U. Bond,et al.  The chicken ubiquitin gene contains a heat shock promoter and expresses an unstable mRNA in heat-shocked cells , 1986, Molecular and cellular biology.

[45]  U. Bond,et al.  Ubiquitin is a heat shock protein in chicken embryo fibroblasts , 1985, Molecular and cellular biology.

[46]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[47]  P. Leigh,et al.  New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies , 2004, Acta Neuropathologica.

[48]  K. Blennow,et al.  Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke. , 2000, Journal of Alzheimer's disease : JAD.

[49]  D. Galasko.  Cerebrospinal fluid levels of Aβ42 and tau: potential markers of Alzheimer’s disease , 1998 .

[50]  M. Rechsteiner,et al.  Ubiquitin-mediated pathways for intracellular proteolysis. , 1987, Annual review of cell biology.

[51]  A. Ciechanover,et al.  The ubiquitin pathway for the degradation of intracellular proteins. , 1986, Progress in nucleic acid research and molecular biology.